LOS ANGELES, Jan. 26, 2023 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) is pleased to announce to investors February 10, 2023 Deadline to File Principal Plaintiff Motions in Class Action Filed on Behalf of Investors Who Purchased or Acquired Common Stock of Twist Bioscience Corporation (“Twist” or “Company”) (NASDAQ: TWST) December 13, 2019 and November 14, 2022inclusive (“class duration”).
If you have suffered a loss on your Twist investment or wish to inquire about the possibility of pursuing a claim to recover your losses under federal securities laws, please visit www.glancelaw.com/cases/twist-bioscience-corporation/ You can send your contact information at You may also contact Charles H. Linehan, GPM at 310-201-9150, toll-free 888-773-9224, or email firstname.lastname@example.org for more information on your rights.
On November 15, 2022, Scorpion Capital released an investigative report, claiming the company was a “cash-burning hell” and “runs a Ponzi-like scheme leading to bankruptcy.” The report further stated that Twist’s allegations of his DNA chip technology were a “farce”, that the company’s growth and earnings were unsustainable, and that the company perpetuated fraud through false reporting of capital expenditures and gross margins. claimed to be
The news sent Twist’s stock price down by $7.57 (19.9%) to close at $30.43 per share on November 15, 2022, hurting investors.
The complaint filed in this class action alleges that, throughout the class, defendants made materially false and/or misleading statements and failed to disclose material adverse facts regarding the company’s business, operations and prospects. I’m here. Specifically, defendants: (1) overestimated the commercial viability of Twist’s synthetic DNA manufacturing technology, engaged in fraudulent accounting, and used unsustainable pricing to undermine the company’s true financial position; and inflated the outlook. (2) as a result, defendant’s positive statements regarding the Company’s business, operations and prospects were materially misleading and/or unreasonable at all relevant times;
Stay up to date on LinkedIn, Twitter, or Facebook.
If you purchase or acquire Twist common stock during a class period, you may transfer to court no later than: February 10, 2023 We request appointment as the lead plaintiff in this putative class action. You do not have to do anything at this time to become a member of the class action. You can retain your attorney of choice or take no action and remain an absent member of the class. If you would like to learn more about this class or if you If you have any questions about your rights or interests, please contact Charles Linehan, GPM, Esquire, 1925 Century Park East, Suite. 2100, Los Angeles, California 90067 Call 310-201-9150, toll free 888-773-9224, email email@example.com or visit www.glancelaw.com. When contacting us by e-mail, please include your mailing address, phone number, and number of shares purchased.
This press release may be considered attorney advertising in some jurisdictions under applicable legal and ethical rules.
Glance Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224